15,805 Shares in HealthEquity, Inc. $HQY Purchased by Simplify Asset Management Inc.

Simplify Asset Management Inc. purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 15,805 shares of the company’s stock, valued at approximately $1,498,000.

Other large investors have also recently added to or reduced their stakes in the company. First American Bank bought a new position in shares of HealthEquity in the third quarter valued at approximately $1,633,000. Mattson Financial Services LLC acquired a new stake in HealthEquity during the 3rd quarter valued at $228,000. Institute for Wealth Management LLC. raised its position in HealthEquity by 112.7% in the 3rd quarter. Institute for Wealth Management LLC. now owns 13,563 shares of the company’s stock valued at $1,285,000 after purchasing an additional 7,187 shares during the last quarter. Three Seasons Wealth LLC bought a new position in HealthEquity in the 3rd quarter valued at $349,000. Finally, Sowell Financial Services LLC acquired a new position in HealthEquity in the third quarter worth $233,000. 99.55% of the stock is owned by institutional investors.

Analysts Set New Price Targets

HQY has been the subject of a number of research reports. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JMP Securities set a $122.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Finally, Royal Bank Of Canada boosted their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $120.27.

Get Our Latest Stock Analysis on HQY

HealthEquity Stock Down 0.7%

Shares of NASDAQ HQY opened at $92.78 on Tuesday. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The firm’s 50-day moving average is $97.27 and its 200-day moving average is $95.66. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $7.93 billion, a PE ratio of 42.56, a price-to-earnings-growth ratio of 1.35 and a beta of 0.18.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same period in the prior year, the business posted $0.78 earnings per share. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,240 shares of company stock worth $1,640,164 in the last three months. Insiders own 1.50% of the company’s stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Read More

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.